BHM part funded in collaboration with Prohealth, 5 x AliveCor KArdia ECG devices. BHM has part funded these devices for a toal amount of € 291.00. The rest of the funds where sponsored by Prohealth. The Kardia device allows assessment of the electricity of the heart by recording a single lead ECG. These devices are mainly used for the outpatient assessment of patients with palpitations. The AliveCor devices will be used in the new outpatient clinic.
We would like to take this opportunity to thank Prohealth for their contribution to this initiative.
